At GTx, They focus on the development of small molecules that selectively modulate the effects of certain hormones produced by the body.
GTx, Inc. is a company of pioneering and driven individuals who are delivering better medicines with new science through established pathways.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 20, 2003 | Series E | $20M | 1 | — | — | Detail |